MA53809A - Composés bifonctionnels comprenant des peptides d'insuline et des peptides d'egf(a) - Google Patents

Composés bifonctionnels comprenant des peptides d'insuline et des peptides d'egf(a)

Info

Publication number
MA53809A
MA53809A MA053809A MA53809A MA53809A MA 53809 A MA53809 A MA 53809A MA 053809 A MA053809 A MA 053809A MA 53809 A MA53809 A MA 53809A MA 53809 A MA53809 A MA 53809A
Authority
MA
Morocco
Prior art keywords
peptides
egf
compounds including
bifunctional compounds
including insulin
Prior art date
Application number
MA053809A
Other languages
English (en)
French (fr)
Inventor
Claudia Ulrich Hjørringgaard
Susanne Hostrup
Thomas Børglum Kjeldsen
Peter Madsen
Martin Werner Borchsenius Münzel
Mathias Norrman
Gro Klitgaard Povlsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MA53809A publication Critical patent/MA53809A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
MA053809A 2018-10-05 2019-10-04 Composés bifonctionnels comprenant des peptides d'insuline et des peptides d'egf(a) MA53809A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18198892 2018-10-05

Publications (1)

Publication Number Publication Date
MA53809A true MA53809A (fr) 2022-01-12

Family

ID=64017248

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053809A MA53809A (fr) 2018-10-05 2019-10-04 Composés bifonctionnels comprenant des peptides d'insuline et des peptides d'egf(a)

Country Status (8)

Country Link
US (1) US11649269B2 (cg-RX-API-DMAC10.html)
EP (1) EP3861017A1 (cg-RX-API-DMAC10.html)
JP (1) JP7434299B2 (cg-RX-API-DMAC10.html)
CN (1) CN112789289A (cg-RX-API-DMAC10.html)
AR (1) AR116605A1 (cg-RX-API-DMAC10.html)
MA (1) MA53809A (cg-RX-API-DMAC10.html)
TW (1) TW202028229A (cg-RX-API-DMAC10.html)
WO (1) WO2020070276A1 (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3939605A1 (en) 2016-12-09 2022-01-19 Akston Biosciences Corporation Insulin-fc fusions and methods of use
US11267862B2 (en) 2018-06-29 2022-03-08 Akston Biosciences Corporation Ultra-long acting insulin-Fc fusion proteins and methods of use
HUE062719T2 (hu) 2018-06-29 2023-11-28 Akston Biosciences Corp Ultra-hosszú hatású inzulin-FC fúziós fehérjék és az alkalmazási eljárások
KR102865175B1 (ko) 2019-12-19 2025-09-30 악스톤 바이오사이언시스 코퍼레이션 초-장기 작용 인슐린-fc 융합 단백질 및 사용 방법
US11186623B2 (en) 2019-12-24 2021-11-30 Akston Bioscience Corporation Ultra-long acting insulin-Fc fusion proteins and methods of use
US11192930B2 (en) 2020-04-10 2021-12-07 Askton Bioscences Corporation Ultra-long acting insulin-Fc fusion protein and methods of use
LT3972987T (lt) 2020-04-10 2023-09-25 Akston Biosciences Corporation Antigenui specifinė imunoterapija, skirta sulietiems covid-19 baltymams ir naudojimo būdai
US11198719B2 (en) 2020-04-29 2021-12-14 Akston Biosciences Corporation Ultra-long acting insulin-Fc fusion protein and methods of use
CA3193453A1 (en) 2020-09-30 2022-04-07 Beijing Ql Biopharmaceutical Co., Ltd. Polypeptide conjugates and methods of uses
US11667689B2 (en) 2021-07-23 2023-06-06 Akston Biosciences Corporation Insulin-Fc fusion proteins and methods of use to treat cancer
EP4323413A4 (en) 2022-03-30 2025-10-15 Beijing Ql Biopharmaceutical Co Ltd LIQUID PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDE CONJUGATES AND METHODS OF USE THEREOF
CN115850385B (zh) * 2022-07-04 2023-08-11 北京惠之衡生物科技有限公司 一种促表达肽及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009022006A1 (en) 2007-08-15 2009-02-19 Novo Nordisk A/S Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids
HUE032284T2 (en) 2008-03-18 2017-09-28 Novo Nordisk As Protease-stabilized, acylated insulin analogues
EP2296694B1 (en) 2008-04-23 2015-08-05 Amgen Inc. Neutralizing proprotein convertase subtilisin kexin type 9 (pcsk9) variants and uses thereof
GB201005005D0 (en) 2010-03-25 2010-05-12 Angeletti P Ist Richerche Bio New vaccine
KR20140041747A (ko) 2011-06-20 2014-04-04 제넨테크, 인크. Pcsk9-결합 폴리펩티드 및 사용 방법
BR112016017402A2 (pt) 2014-02-21 2017-10-17 Medimmune Ltd fusões anti-pcsk9~glp-1 e métodos para uso
CN104558199B (zh) 2014-09-05 2018-07-06 成都康弘生物科技有限公司 一种治疗高胆固醇血症的融合蛋白制备及其用途
WO2016164762A1 (en) 2015-04-08 2016-10-13 Moderna Therapeutics, Inc. Polynucleotides encoding low density lipoprotein receptor egf-a and intracellular domain mutants and methods of using the same
BR112018002416A2 (pt) 2015-08-25 2018-09-18 Novo Nordisk As derivados de insulina e seus usos médicos
RU2747877C2 (ru) 2016-01-13 2021-05-17 Ново Нордиск А/С Аналоги эфр(а) с заместителями - жирными кислотами

Also Published As

Publication number Publication date
US11649269B2 (en) 2023-05-16
WO2020070276A1 (en) 2020-04-09
EP3861017A1 (en) 2021-08-11
US20220009989A1 (en) 2022-01-13
AR116605A1 (es) 2021-05-26
TW202028229A (zh) 2020-08-01
JP2022504153A (ja) 2022-01-13
CN112789289A (zh) 2021-05-11
JP7434299B2 (ja) 2024-02-20

Similar Documents

Publication Publication Date Title
EP4086280A4 (en) INSULIN DERIVATIVE
EP3925652A4 (en) SAFE INSULIN NEEDLE
EP3876770A4 (en) VAPORIZER DEVICE WITH MORE THAN ONE HEATING ELEMENT
EP3794397A4 (en) CLOSE-UP DISPLAY WITH OVERLAPPING PROJECTOR ARRANGEMENTS
EP3823179A4 (en) USER EQUIPMENT
EP3823543A4 (en) CLIP APPLICATOR AND CASSETTE
EP3694582A4 (en) INJECTION DEVICE WITH ADHESIVE ARRANGEMENT
EP3870257A4 (en) CASSETTE UNIT COUPLER
EP3902564A4 (en) IGG-FC VARIANTS FOR USE IN VETERINARY MEDICINE
EP3731569A4 (en) USER EQUIPMENT
IL279901A (en) Antibodies comprising a polypeptide inserted in framework 3 region
EP3820055A4 (en) USER DEVICE
EP4085775A4 (en) HEATER AND SMOKE DEVICE WITH HEATER
GB201803990D0 (en) Joint d'etancheite air-feu et assemblage comprenant un tel joint
EP3918854A4 (en) LOCATION OF USER DEVICES
EP3833094A4 (en) USER DEVICE
EP3836702A4 (en) USER EQUIPMENT
EP3817582A4 (en) CARTRIDGE AND AEROSOL GENERATING DEVICE WITH IT
EP3761697A4 (en) USER DEVICE
EP3920750A4 (en) HAIR STRAIGHTENER WITH CERAMIC HEATING ELEMENT
EP3968970A4 (en) LOCAL ANESTHETICS WITH A TRP CHANNEL MODULATOR
EP3817259A4 (en) USER DEVICE
EP3817584A4 (en) CARTRIDGE AND AEROSOL GENERATING DEVICE WITH IT
EP3906373A4 (en) MODULAR INPUT INTERFACE DEVICE WITH MULTIAXIAL INTERACTION
EP3832923A4 (en) USER DEVICE